IXHL — Incannex Healthcare Income Statement
0.000.00%
Last trade - 00:00- $3.66m
- $5.33m
- $0.01m
Annual income statement for Incannex Healthcare, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | 10-K | 10-K |
| Standards: | IFRS | IFRS | IFRS | USG | USG |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.551 | 1.47 | 0.572 | 0 | 0.012 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.18 | 9.95 | 11.4 | 49.7 | 30.1 |
| Operating Profit | -2.63 | -8.48 | -10.8 | -49.7 | -30 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.63 | -8.48 | -10.8 | -48.8 | -18.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.63 | -8.48 | -10.8 | -48.8 | -18.5 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.15 | -8.48 | -10.8 | -48.8 | -18.5 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.15 | -8.48 | -10.8 | -48.8 | -18.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | -0.009 | -0.009 | -0.875 | -1.14 |